VentureBlick Discovery
Tech Scouting – Partner with a Global Diagnostics Leader on Alternative Blood Sampling Through VentureBlick image
申请已关闭

Tech Scouting – Partner with a Global Diagnostics Leader on Alternative Blood Sampling Through VentureBlick

  • 概览We are excited to present a rare opportunity for companies to collaborate with a global diagnostics leader, in partnership with VentureBlick. Our partner is seeking innovative solutions for Alternative Blood Sampling (ABS) – specifically, single-use devices for self-collection of capillary blood. This project offers startups a chance to make a significant impact on the future of patient care.
  • 机会Commercial Partnership with Global Healthcare Diagnostics Leader
  • 申请期10月 03, 2024 - 10月 31, 2024

Tech Scouting Requirement:

Alternative Blood Sampling (ABS): Single-use devices for self-collection of capillary blood.

The device should:

  • Have a minimal collection volume of 500 microliters.

  • Be non-finger prick based.

  • Be user-friendly, reliable, and cost-effective, ensuring wide adoption.

Problem Statement:

Current methods of capillary blood collection, particularly finger-prick techniques, present several challenges. They often cause discomfort for patients, lead to inconsistent sample quality, and may fail to collect the required volume for more comprehensive testing. These issues are especially problematic for individuals who need frequent monitoring or testing, such as those with chronic conditions.

There is a growing need for a more patient-friendly, reliable, and effective solution that can collect sufficient blood volume (500 microliters) without relying on finger-prick methods.

This new approach should aim to reduce patient discomfort, improve the quality and consistency of samples, and be easy to use for self-collection. Developing such a solution will not only enhance the patient experience but also make self-administered blood sampling more feasible for broader applications, including at-home care.

Why Apply?

This is a rare opportunity for select companies to collaborate directly with a global diagnostics leader. Only the most promising innovations will be considered, with the potential for commercial partnership. Your solution could redefine self-administered blood sampling and set a new standard for patient care.

Submissions close on 25th October. Don't miss out—apply today!

For inquiries, please contact startup.relations@ventureblick.com